Foley’s Health Care Industry Team is frequently asked to assist clients in identifying key compliance risks on an industry-wide basis. Foley Partners Maria E. Gonzalez Knavel and Lawrence W. Vernaglia presented our best estimates for the “top 10” compliance risks for hospitals and health systems in 2008. Of course, every hospital has its own unique set of challenges, and the list below is not meant to be exhaustive nor to exclude other issues from compliance review.
- Medicaid — Deficit Reduction Act (DRA) and False Claims Act
- Board of directors involvement — structural issues
- Centers for Medicare & Medicaid Services (CMS) data mining implications
- Recovery audit contractor (RAC) audits and other new predators
- Research, clinical trials billing, time, and effort reporting
- Medicare severity diagnosis related groups
- Present On Admission and Hospital Acquired Conditions
- “Supplemental” and certification/status payments
- Stark Phase III — physician-hospital relations
- Quality
Related Insights
July 22, 2025
Health Care Law Today
GLP-1 Receptor Agonists: Clinical Trial Considerations
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
July 21, 2025
Energy Current
DOE Announces Pilot Program to Build Advanced U.S. Nuclear Fuel Supply Lines: What You Need to Know Now
Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in…
July 21, 2025
Labor & Employment Law Perspectives
Considering a Reduction in Force? Some Preliminary Considerations
Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs…